Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enping Xu

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Pathology|March 29, 2022
Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020)Haiyan Shi, Ying Shao, Huilin Zhang, et al.
Pathology, Research and Practice|April 30, 2021
Methylation status of ADAM12 promoter are associated with its expression levels in colorectal cancerYan Wang, Jing Zhang, Hui Cao, et al.
Virchows Archiv : an International Journal of Pathology|September 7, 2006
Secretagogin, a novel neuroendocrine marker, has a distinct expression pattern from chromogranin AMaode Lai, Bingjian Lü, Xiaoming Xing, et al.
Biochemical and Biophysical Research Communications|October 16, 2004
A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancerEnping Xu, Maode Lai, Bingjian Lv, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 2, 2013
Risk assessment of esophageal adenocarcinoma using γ-H2AX assayEnping Xu, Yilei Gong, Jian Gu, et al.
Carcinogenesis|June 28, 2013
Association of mitochondrial DNA copy number in peripheral blood leukocytes with risk of esophageal adenocarcinomaEnping Xu, Wenjie Sun, Jian Gu, et al.
Journal of Cellular and Molecular Medicine|June 17, 2016
HOTAIRM1 as a potential biomarker for diagnosis of colorectal cancer functions the role in the tumour suppressorLedong Wan, Jianlu Kong, Jinlong Tang, et al.
Journal of Biochemical and Biophysical Methods|June 9, 2005
DHPLC analysis of the matrix metalloproteinase-1 promoter 1G/2G polymorphism that can be easily used to screen large populationEnping Xu, Maode Lai, Bingjian Lv, et al.
Proteomics|April 6, 2006
Identification of differentially expressed proteins in colorectal cancer by proteomics: down-regulation of secretagoginXiaoming Xing, Maode Lai, Wolfgang Gartner, et al.
Experimental Cell Research|December 2, 2021
The expression of ADAMTS14 is regulated by promoter DNA methylation and is associated with poor prognosis in colorectal cancerYan Wang, Jing Zhou, Jing Zhang, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Pathology|March 29, 2022
Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020)Haiyan Shi, Ying Shao, Huilin Zhang, et al.
Pathology, Research and Practice|April 30, 2021
Methylation status of ADAM12 promoter are associated with its expression levels in colorectal cancerYan Wang, Jing Zhang, Hui Cao, et al.
Virchows Archiv : an International Journal of Pathology|September 7, 2006
Secretagogin, a novel neuroendocrine marker, has a distinct expression pattern from chromogranin AMaode Lai, Bingjian Lü, Xiaoming Xing, et al.
Biochemical and Biophysical Research Communications|October 16, 2004
A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancerEnping Xu, Maode Lai, Bingjian Lv, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 2, 2013
Risk assessment of esophageal adenocarcinoma using γ-H2AX assayEnping Xu, Yilei Gong, Jian Gu, et al.
Carcinogenesis|June 28, 2013
Association of mitochondrial DNA copy number in peripheral blood leukocytes with risk of esophageal adenocarcinomaEnping Xu, Wenjie Sun, Jian Gu, et al.
Journal of Cellular and Molecular Medicine|June 17, 2016
HOTAIRM1 as a potential biomarker for diagnosis of colorectal cancer functions the role in the tumour suppressorLedong Wan, Jianlu Kong, Jinlong Tang, et al.
Journal of Biochemical and Biophysical Methods|June 9, 2005
DHPLC analysis of the matrix metalloproteinase-1 promoter 1G/2G polymorphism that can be easily used to screen large populationEnping Xu, Maode Lai, Bingjian Lv, et al.
Proteomics|April 6, 2006
Identification of differentially expressed proteins in colorectal cancer by proteomics: down-regulation of secretagoginXiaoming Xing, Maode Lai, Wolfgang Gartner, et al.
Experimental Cell Research|December 2, 2021
The expression of ADAMTS14 is regulated by promoter DNA methylation and is associated with poor prognosis in colorectal cancerYan Wang, Jing Zhou, Jing Zhang, et al.
Pageof 5